# Phase 50 — Acceptance Criteria (Production-Acceptance style)

Kickoff checklist for **future** Phase 50 Production Acceptance.  
**This document does not accept Phase 50.** No implementation in this package.

**SSOT:** `PHASE_50_FROZEN_SCOPE_EXTRACT.md` + CTO Phase 50 authorize + agreed CI baselines.

---

## 0. Entry gates (preconditions)

- [ ] Canonical base includes Phase 49 merge (`1501190` or later accepted tip on lineage).
- [ ] Phase 49 PA remains **ACCEPTED**; Phase 48 Waves A–I remain **OFFICIALLY CLOSED**.
- [ ] Explicit CTO **implementation** authority granted for Phase 50 slices (kickoff alone is insufficient).
- [ ] Wave A–I / Phase 49 SoR remain closed (no reopen without new product failure + CTO).
- [ ] Framework remains existing CI/test philosophy — no second test framework.
- [ ] No full brand redesign / polish dump required for acceptance.

---

## 1. Polish invariants (must hold)

| Invariant | Required |
|-----------|----------|
| Docs polish / operator clarity inventory + authorized docs slices | YES |
| Bounded UX polish only via thin CTO-authorized slices | YES |
| A11y follow-ups inventoried; authorized items closed or deferred with owners | YES |
| AppointmentForm clinical-catalog picker: delivered **or** explicitly deferred on accepting SHA | YES |
| Owner UX (names vs truncated UUIDs): inventoried; authorized candidates closed or deferred | YES |
| Agreed CI baselines remain green | YES |
| Flakes fixed deterministically — not silenced | YES |
| No second test framework | YES |
| No Wave A–I / Phase 49 SoR reopen | YES |

---

## 2. Behavioral / deliverable acceptance

### Docs / operator clarity

- [ ] Inventory of operator-facing docs gaps complete for accepting SHA.
- [ ] Authorized thin docs polish slices landed (cross-links, clarity — not new ops product).

### Bounded UX polish

- [ ] Candidate list from discovery; only authorized thin UX changes shipped.
- [ ] No brand redesign / dump required for PA.

### A11y follow-ups

- [ ] Follow-up inventory exists; authorized fixes evidenced; remaining items deferred with owners.

### AppointmentForm clinical-catalog picker

- [ ] Either CTO-authorized slice delivered with evidence, **or** accepting SHA records explicit deferral (still OUT until authorized).

### Owner UX (names vs UUIDs)

- [ ] Surfaces inventoried; authorized replacements of truncated UUID-only display delivered or deferred.

---

## 3. Explicit non-goals (acceptance must NOT require)

- Phase 51 commercial launch.
- Reopening Wave A–I or Phase 49 SoR.
- Full brand redesign / polish dump.
- Declaring PASS because Phase 49 or Wave I once passed historically.
- Self-granted Phase 50 Production Acceptance.
- Second test framework.

---

## 4. Exit sign-off block (for later CTO use)

```text
PHASE 50 PRODUCTION ACCEPTANCE = ________ (PENDING / ACCEPTED)
Evidence SHA = ________
Docs / operator clarity = ________
Bounded UX polish = ________
A11y follow-ups = ________
AppointmentForm clinical-catalog picker = ________ (DELIVERED / DEFERRED)
Owner UX names vs UUIDs = ________
CI baselines remain green = ________
Phase 51 commercial launch = NOT REQUIRED
Wave A–I / Phase 49 SoR reopen = NOT REQUIRED
full brand redesign = NOT REQUIRED
```

```text
self-granted Phase 50 PA = NO
Phase 50 Production Acceptance = PENDING
```
